A

Active Director Director DIN 08951393
DIN 08951393 First appointment Nov 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value •••• Premium profile

About Anitha

Data last updated:

Anitha is a Director at Kainopharm Limited (since 2020). The company operates in Pharma. Kainopharm Limited reported revenue of ₹2.66 Cr (FY 2025).

DIN 08951393
Primary Designation Director
Industry Pharma
First Appointment 15 Nov 2020
Oldest Company Age 6 yrs
Largest company Kainopharm Limited · ₹2.66 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kainopharm Limited U33100KL2020PLC063719
Director15 Nov 20202020₹2.66 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Kainopharm Limited
Premium access

Shareholding and investment profile for Anitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anitha

Anitha currently holds 1 directorship: Kainopharm Limited (Director, since 15 Nov 2020, revenue ₹2.66 Cr (FY 2025)).

Anitha was first appointed on 15 Nov 2020 as Director at Kainopharm Limited.

The current boards of Anitha's companies include Abdul Latheef (Kainopharm Limited), Anilkumar Bhaskaran Nair (Kainopharm Limited), Attupuram Sreekumar (Kainopharm Limited), Jaison George (Kainopharm Limited), Kuzhalmannam Lakshminarayanan Sreeram (Kainopharm Limited), Mohanakurup Anjiliparambil Narayanapillai (Kainopharm Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available